ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
636.56%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total assets
Total assets on the balance sheet as of September 2023 : $0.82 B
According to ImmunoGen 's latest financial reports the company's total assets are $0.82 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ImmunoGen - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.34 B | -33.63% |
| 2021-12-31 | $0.52 B | 48.07% |
| 2020-12-31 | $0.35 B | 50.93% |
| 2019-12-31 | $0.23 B | -20.35% |
| 2018-12-31 | $0.29 B | 0.24% |
| 2017-12-31 | $0.29 B | |
| 2016-06-30 | $0.27 B | -9.41% |
| 2015-06-30 | $0.30 B | 86.46% |
| 2014-06-30 | $0.16 B | -22.6% |
| 2013-06-30 | $0.21 B | 18.46% |
| 2012-06-30 | $0.18 B | -17.15% |
| 2011-06-30 | $0.21 B | 58.62% |
| 2010-06-30 | $0.13 B | 36.25% |
| 2009-06-30 | $0.10 B | 20.84% |
| 2008-06-30 | $83.33 M | 3.63% |
| 2007-06-30 | $80.42 M | -14.56% |
| 2006-06-30 | $94.12 M | -14.53% |
| 2005-06-30 | $0.11 B | -10.19% |
| 2004-06-30 | $0.12 B | 3.9% |
| 2003-06-30 | $0.11 B | -22.43% |
| 2002-06-30 | $0.15 B | -4.4% |
| 2001-06-30 | $0.15 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 20,281.68% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | 12,057.27% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 27,451.48% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 7,685.70% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 11,717.77% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 16,907.16% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $95.15 B | 11,475.10% | 🇺🇸 USA |
 Seagen
SGEN | $3.63 B | 342.07% | 🇺🇸 USA |